Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Abivax, Aerpio, Aim, Alteogen, Apellis, Apollomics, Atea, Bharat, Brii, Can-Fite, Cerecor, Cytodyn, Glaxosmithkline, Immunitybio, Immutep, Innovation, Longeveron, Merck, Morphosys, Nantkwest, Ocugen, Ridgeback, Roche, Vir.